Medpace (MEDP) finished the latest trading session at $324.13, which represents a 1.55% increase from the previous day's closing price.
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national firm that protects shareholder rights, is looking into claims from investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national firm that protects shareholder rights, is looking into claims from investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national firm that protects shareholder rights, is looking into claims from investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / February 26, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national firm that protects shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / February 23, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims from investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
Madison Investments, an investment advisory firm, published its fourth-quarter 2024 letter to investors for the "Madison Small Cap Fund." You can download the letter here. The fund had a successful year, achieving impressive returns both in the fourth quarter and throughout the entire year.
LOS ANGELES, CA / ACCESS Newswire / February 17, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.